Form 4: InfuSystem Holdings Director Scott Shuda Reports Share Distribution

Director Scott Shuda reports the distribution of 42,241 shares of InfuSystem Holdings common stock from BlueLine Capital Partners II, LP.

Summary

• Scott Shuda, a director at InfuSystem Holdings, reported a transaction involving the distribution of 42,241 shares of common stock.
• The shares were distributed by BlueLine Capital Partners II, LP to its limited partners.
• Mr. Shuda serves as Managing Director of entities that control both Meridian OHC Partners, LP and BlueLine Capital Partners II, LP.
• He has voting and dispositive power over the shares held by these entities but disclaims beneficial ownership for the purposes of Rule 13d-3.
• Following the transaction, Mr. Shuda indirectly owns 298,383 shares of InfuSystem Holdings common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing and does not indicate any positive or negative sentiment. It is a neutral disclosure of a transaction.

Industry Context

This is a standard SEC Form 4 filing, which is a routine disclosure for corporate insiders regarding changes in their beneficial ownership of company stock. It does not indicate any specific trend in the medical device industry.

Comparison to Industry Standards

• Form 4 filings are a standard practice for all publicly traded companies in the US.
• The level of detail and the type of information disclosed are consistent with SEC regulations.
• The transaction is a distribution of shares from a private fund to its partners, which is a common occurrence in the investment management industry.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a distribution of shares from a private fund to its partners and does not involve the company directly.

Key Dates

Keywords

InfuSystem Holdings, Scott Shuda, share distribution, beneficial ownership, Form 4, director, BlueLine Capital Partners II, Meridian OHC Partners